Back to Trials
NCT06258109Recruiting

Risk of Recurrent CeAD After Pregnancy

University Hospital, Basel, Switzerland

Start Date

1/1/2023

Completion Date

7/1/2025

Summary

Primary objective: To determine whether pregnancy increases the risk of recurrent CeAD and delayed stroke in women with prior CeAD based on long-term data. Methods: Multicentric, observational case-control study based on pooled individual patient data from several stroke centers. Primary endpoint: Primary composite outcome measure includes the following outcomes: (i) occurrence of recurrent CeAD, (ii) occurrence of ischemic or hemorrhagic stroke, (iii) death.

Detailed Description

Background: Cervical artery dissection (CeAD) is a leading cause of stroke in women of childbearing age. Among the population with an initial CeAD, about 9% show a recurrence event (a range from 0 to 25% has been reported). Recurrence of CeAD can occur for several years after the initial event. CeAD has been shown to occur in association with pregnancy, and the postpartum period, yet it remains unclear whether pregnancy increases the risk of recurrence or delayed stroke. Previous studies on this subject are either based on small sample sizes or lack long-term data. Objective: The investigators want to determine whether pregnancy increases the risk of recurrent CeAD and delayed stroke in women with prior CeAD based on long-term data. Furthermore, it will be investigated whether the mode of delivery affects recurrence and if dissections occurred during a particular phase of a woman's reproductive process. The investigators will also investigate if women actively decided against another pregnancy due to the initial CeAD. Methods: This study will be a multicenter, exploratory case-control study using pooled individual patient data from several stroke centers. The data will be obtained through review of medical records and patient interviews. The study will include all women with any prior CeAD who have had long-term follow-up (at least 6 months, with no upper limit), including information about pregnancy and recurrence of CeAD. Primary endpoint is a composite outcome measure which consists of (i) occurrence of recurrent CeAD, (ii) occurrence of ischemic or hemorrhagic stroke, (iii) death. Secondary endpoints are the individual components of the primary endpoint and functional outcome assessed by the modified Ranking scale. Statistical analysis will be used to determine the odds of the primary and secondary endpoints in women who had subsequent pregnancies compared to those who did not.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * female * prior symptomatic cervical artery dissection (= index CeAD) * at least one long-term follow-up visit (at least 6 months after the initial event) * with information available on outcome events: * recurrent dissection * ischemic stroke * hemorrhagic stroke * functional outcome assessed by mRS score * with data on pregnancy after the initial event * at least 18 years old at the initial event Exclusion Criteria: * Male patients * Age \<18 years * No long-term follow-up available or long-term follow-up \< 6 months after initial event * No data on pregnancy after initial event available

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Cervical Artery DissectionPregnancy Complications

Locations

University of Utah

Salt Lake City, Utah 84112

United States

University of Virginia

Charlottesville, Virginia 22908

United States

Stroke Unit Sanatorio Allende

Córdoba, X5000BFB

Argentina

Department of Neurology, Medical University of Innsbruck

Innsbruck, Tyrol 6020

Austria

Helsinki University Central Hospital

Helsinki,

Finland

Charité Universitätsmedizin, Centrum für Schlaganfallforschung

Berlin, 10117

Germany

Neurologische Klinik und Poliklinik, LMU Klinikum Campus Großhadern

Munich, 81377

Germany

Hadassah-Hebrew University Medical Center

Jerusalem, 91120

Israel

Neurology Clinic, University of Brescia

Brescia,

Italy

Stroke Clinic, National Institute of Neurology and Neurosurgery Manuel Velasco Suárez

Mexico City, 14269

Mexico

University Hospital Basel, Stroke Center

Basel, 4031

Switzerland

University Hospital Zurich, Stroke Center

Zurich,

Switzerland